Edit search
Year 2 efficacy results of 2 randomized controlled clinical …
Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
Article, Chapter
Authors: U. Chakravarthy
Publication: Volume:113, Issue:9, Page(s):1508.e1-25
Published: 2006
Browse related articles
  Request a copy of this item
Cite this item